ATE365530T1 - Retinolthaltiges, stabilisiertes hautpflegemittel zur äusserlichen anwendung - Google Patents

Retinolthaltiges, stabilisiertes hautpflegemittel zur äusserlichen anwendung

Info

Publication number
ATE365530T1
ATE365530T1 AT04000012T AT04000012T ATE365530T1 AT E365530 T1 ATE365530 T1 AT E365530T1 AT 04000012 T AT04000012 T AT 04000012T AT 04000012 T AT04000012 T AT 04000012T AT E365530 T1 ATE365530 T1 AT E365530T1
Authority
AT
Austria
Prior art keywords
skin care
product containing
care product
external use
retinol
Prior art date
Application number
AT04000012T
Other languages
English (en)
Inventor
Takeshi Yanagida
Okihiko Sakamoto
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27584926&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE365530(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from JP22773292A external-priority patent/JP3192234B2/ja
Priority claimed from JP22773192A external-priority patent/JPH0632713A/ja
Priority claimed from JP22772992A external-priority patent/JP3455553B2/ja
Priority claimed from JP4227725A external-priority patent/JP2794252B2/ja
Priority claimed from JP22773092A external-priority patent/JPH0632712A/ja
Priority claimed from JP22773892A external-priority patent/JP3313148B2/ja
Priority claimed from JP22773792A external-priority patent/JPH0632719A/ja
Priority claimed from JP22773392A external-priority patent/JP3417419B2/ja
Priority claimed from JP22772792A external-priority patent/JPH0632729A/ja
Priority claimed from JP22773692A external-priority patent/JPH0632718A/ja
Priority claimed from JP22773592A external-priority patent/JP3192235B2/ja
Priority claimed from JP22773992A external-priority patent/JP3582016B2/ja
Priority claimed from JP22772892A external-priority patent/JP3545429B2/ja
Priority claimed from JP22773492A external-priority patent/JP3280712B2/ja
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Publication of ATE365530T1 publication Critical patent/ATE365530T1/de
Application granted granted Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/738—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/51—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A61Q1/06—Lipsticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
AT04000012T 1992-07-13 1993-07-13 Retinolthaltiges, stabilisiertes hautpflegemittel zur äusserlichen anwendung ATE365530T1 (de)

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
JP22772792A JPH0632729A (ja) 1992-07-13 1992-07-13 皮膚外用剤
JP4227725A JP2794252B2 (ja) 1992-07-13 1992-07-13 皮膚外用剤
JP22773192A JPH0632713A (ja) 1992-07-13 1992-07-13 皮膚外用剤
JP22773892A JP3313148B2 (ja) 1992-07-13 1992-07-13 皮膚外用剤
JP22773792A JPH0632719A (ja) 1992-07-13 1992-07-13 皮膚外用剤
JP22773292A JP3192234B2 (ja) 1992-07-13 1992-07-13 皮膚外用剤
JP22772992A JP3455553B2 (ja) 1992-07-13 1992-07-13 皮膚外用剤
JP22773092A JPH0632712A (ja) 1992-07-13 1992-07-13 皮膚外用剤
JP22773392A JP3417419B2 (ja) 1992-07-13 1992-07-13 皮膚外用剤
JP22773992A JP3582016B2 (ja) 1992-07-13 1992-07-13 皮膚外用剤
JP22772892A JP3545429B2 (ja) 1992-07-13 1992-07-13 レチノール安定配合皮膚外用剤
JP22773492A JP3280712B2 (ja) 1992-07-13 1992-07-13 皮膚外用剤
JP22773592A JP3192235B2 (ja) 1992-07-13 1992-07-13 皮膚外用剤
JP22773692A JPH0632718A (ja) 1992-07-13 1992-07-13 皮膚外用剤

Publications (1)

Publication Number Publication Date
ATE365530T1 true ATE365530T1 (de) 2007-07-15

Family

ID=27584926

Family Applications (2)

Application Number Title Priority Date Filing Date
AT93914997T ATE266999T1 (de) 1992-07-13 1993-07-13 Dermatologische zusammensetzung
AT04000012T ATE365530T1 (de) 1992-07-13 1993-07-13 Retinolthaltiges, stabilisiertes hautpflegemittel zur äusserlichen anwendung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT93914997T ATE266999T1 (de) 1992-07-13 1993-07-13 Dermatologische zusammensetzung

Country Status (6)

Country Link
US (2) US5484816A (de)
EP (3) EP0608433B1 (de)
KR (1) KR100295030B1 (de)
AT (2) ATE266999T1 (de)
ES (2) ES2221921T3 (de)
WO (1) WO1994001074A1 (de)

Families Citing this family (121)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962000A (en) * 1992-07-13 1999-10-05 Shiseido Company, Ltd. External skin treatment composition
AU7532794A (en) * 1993-07-26 1995-02-20 Unilever Plc Cosmetic composition containing alpha hydroxy acids
US5681380A (en) 1995-06-05 1997-10-28 Kimberly-Clark Worldwide, Inc. Ink for ink jet printers
US6211383B1 (en) 1993-08-05 2001-04-03 Kimberly-Clark Worldwide, Inc. Nohr-McDonald elimination reaction
US6017471A (en) 1993-08-05 2000-01-25 Kimberly-Clark Worldwide, Inc. Colorants and colorant modifiers
US5733693A (en) 1993-08-05 1998-03-31 Kimberly-Clark Worldwide, Inc. Method for improving the readability of data processing forms
US6017661A (en) 1994-11-09 2000-01-25 Kimberly-Clark Corporation Temporary marking using photoerasable colorants
US5645964A (en) 1993-08-05 1997-07-08 Kimberly-Clark Corporation Digital information recording media and method of using same
WO1997001605A1 (en) 1995-06-28 1997-01-16 Kimberly-Clark Worldwide, Inc. Novel colorants and colorant modifiers
US6242057B1 (en) 1994-06-30 2001-06-05 Kimberly-Clark Worldwide, Inc. Photoreactor composition and applications therefor
US6071979A (en) 1994-06-30 2000-06-06 Kimberly-Clark Worldwide, Inc. Photoreactor composition method of generating a reactive species and applications therefor
US5685754A (en) 1994-06-30 1997-11-11 Kimberly-Clark Corporation Method of generating a reactive species and polymer coating applications therefor
US5976555A (en) * 1994-09-07 1999-11-02 Johnson & Johnson Consumer Products, Inc. Topical oil-in-water emulsions containing retinoids
AU3633295A (en) * 1994-09-07 1996-03-27 Johnson & Johnson Consumer Products, Inc. Retinoid compositions
US6461622B2 (en) * 1994-09-07 2002-10-08 Johnson & Johnson Consumer Companies, Inc. Topical compositions
US6008268A (en) 1994-10-21 1999-12-28 Kimberly-Clark Worldwide, Inc. Photoreactor composition, method of generating a reactive species, and applications therefor
CA2219450A1 (en) 1995-06-05 1996-12-12 Ronald Sinclair Nohr Novel pre-dyes
US5855655A (en) 1996-03-29 1999-01-05 Kimberly-Clark Worldwide, Inc. Colorant stabilizers
US6099628A (en) 1996-03-29 2000-08-08 Kimberly-Clark Worldwide, Inc. Colorant stabilizers
US5782963A (en) 1996-03-29 1998-07-21 Kimberly-Clark Worldwide, Inc. Colorant stabilizers
WO1997020000A2 (en) * 1995-11-28 1997-06-05 Kimberly-Clark Worldwide, Inc. Improved colorant stabilizers
US5851538A (en) * 1995-12-29 1998-12-22 Advanced Polymer Systems, Inc. Retinoid formulations in porous microspheres for reduced irritation and enhanced stability
AR006049A1 (es) 1996-03-01 1999-07-21 Johnson & Johnson Consumer Una emulsion de aceite en agua
US5891229A (en) 1996-03-29 1999-04-06 Kimberly-Clark Worldwide, Inc. Colorant stabilizers
DE19632840A1 (de) * 1996-08-14 1998-02-19 Landsberger Albert Vitamin A-haltige Zusammensetzung
US5744148A (en) * 1996-09-20 1998-04-28 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Stabilization of an unstable retinoid in oil-in-water emulsions for skin care compositions
ID21932A (id) * 1996-09-27 1999-08-12 Unilever Nv Komposisi perawatan kulit yang mengandung kombinasi senyawa-senyawa untuk meniru pengaruh asam retinoat pada kulit
DE19713092A1 (de) * 1997-03-27 1998-10-01 Wacker Chemie Gmbh Komplexe aus Gamma-Cyclodextrin und Retinol bzw. Retinol-Derivaten sowie Verfahren zu ihrer Herstellung und ihre Verwendung
DE19718318A1 (de) * 1997-04-30 1998-11-05 Beiersdorf Ag Wirkstoffkombinationen bzw. Addukte aus Dibenzoylmethanderivaten und/oder Zimtsäurederivaten und Cyclodextrinen und Verwendung solcher Wirkstoffkombinationen in kosmetischen Lichtschutzzubereitungen
FR2763853B1 (fr) * 1997-05-28 2000-01-07 Oreal Association d'un retinoide avec un polymere polyamine
US6524379B2 (en) 1997-08-15 2003-02-25 Kimberly-Clark Worldwide, Inc. Colorants, colorant stabilizers, ink compositions, and improved methods of making the same
IN187860B (de) * 1997-08-27 2002-07-06 Revlon Consumer Prod Corp
US5972355A (en) * 1997-09-30 1999-10-26 E-L Management Corp. Stable compositions containing biologically active components
JP2000516643A (ja) * 1998-05-07 2000-12-12 ザ、プロクター、エンド、ギャンブル、カンパニー アスコルビン酸化合物を含む組成物
CA2298468A1 (en) 1998-06-03 1999-12-09 John Gavin Macdonald Novel photoinitiators and applications therefor
WO1999063006A2 (en) 1998-06-03 1999-12-09 Kimberly-Clark Worldwide, Inc. Neonanoplasts produced by microemulsion technology and inks for ink jet printing
EP1100852A1 (de) 1998-07-20 2001-05-23 Kimberly-Clark Worldwide, Inc. Verbesserte tintenstrahldrucktinten-zusammensetzungen
EP0988854B1 (de) 1998-09-21 2004-07-14 Shiseido Company Limited Zusammensetzung zur äusserlichen Anwendung enthaltend Succinoglucan, Tonerde und ein Alkylacrylat/methacrylat Copolymer
PL366326A1 (en) 1998-09-28 2005-01-24 Kimberly-Clark Worldwide, Inc. Novel photoinitiators and applications therefor
MY123201A (en) * 1998-11-06 2006-05-31 Kao Corp Plant-activating agent
DE60002294T2 (de) 1999-01-19 2003-10-30 Kimberly Clark Co Farbstoffe, farbstoffstabilisatoren, tintenzusammensetzungen und verfahren zu deren herstellung
US6331056B1 (en) 1999-02-25 2001-12-18 Kimberly-Clark Worldwide, Inc. Printing apparatus and applications therefor
US6294698B1 (en) 1999-04-16 2001-09-25 Kimberly-Clark Worldwide, Inc. Photoinitiators and applications therefor
US6368395B1 (en) 1999-05-24 2002-04-09 Kimberly-Clark Worldwide, Inc. Subphthalocyanine colorants, ink compositions, and method of making the same
DE19943678A1 (de) * 1999-09-13 2001-03-15 Beiersdorf Ag Wirkstoffkombinationen aus oberflächenaktiven Citronensäureestern und Einschlußverbindungen von Cyclodextrinen und Retinoiden sowie kosmetische und dermatologische Zubereitungen mit einem Gehalt an solchen Gemischen
DE10003786A1 (de) * 2000-01-28 2001-08-02 Merck Patent Gmbh Galenische Formulierung
JP3503884B2 (ja) * 2000-01-28 2004-03-08 花王株式会社 化粧料
US6531141B1 (en) 2000-03-07 2003-03-11 Ortho-Mcneil Pharmaceutical, Inc. Oil-in-water emulsion containing tretinoin
KR100404868B1 (ko) * 2000-03-28 2003-11-15 김삼 안정한 레티놀 팔미테이트 및 그를 함유하는 화장료 조성물
US6468552B1 (en) 2000-06-02 2002-10-22 Neutrogena Corporation Stabilized compositions containing oxygen-labile active agents
US6353029B1 (en) * 2000-08-24 2002-03-05 Bristol-Myers Squibb Company Storage stable tretinoin and 4-hydroxyanisole containing topical composition
JP3763567B2 (ja) * 2001-01-19 2006-04-05 株式会社資生堂 化粧料
WO2003015494A2 (en) * 2001-08-21 2003-02-27 Galileo Pharmaceuticals, Inc. Tocopherol enriched compositions and amelioration of inflammatory symptoms
US20030059446A1 (en) * 2001-09-18 2003-03-27 Kulkarni Arun B. Physically stable sprayable gel composition
US6830746B2 (en) 2001-09-21 2004-12-14 Playtex Products, Inc. Sunscreen compositions
DE10151245A1 (de) * 2001-10-17 2003-05-15 Beiersdorf Ag Kosmetische und/oder dermatologische Wirkstoffkombination
WO2003043570A2 (en) * 2001-11-15 2003-05-30 Galileo Laboratories, Inc. Formulations and methods for treatment or amelioration of inflammatory conditions
CN100441169C (zh) * 2001-12-21 2008-12-10 爱尔康公司 合成的无机纳米微粒作为载体在眼用和耳用的药物中的应用
KR20040073503A (ko) * 2001-12-21 2004-08-19 알콘, 인코퍼레이티드 안과용 및 이과용 약제학적 조성물의 점도 및 기타물리학적 성질을 개질시키기 위한 무기 나노입자의 용도
FR2835434B1 (fr) * 2002-02-01 2006-03-03 Lvmh Rech Utilisation cosmetique ou dermatologique de la vitamine a ou de ses esters, en association avec une beta-cyclodextrine partiellement methylee
US20030165546A1 (en) * 2002-03-04 2003-09-04 The Procter & Gamble Company Stable personal care compositions containing a retinoid
DE10218181A1 (de) * 2002-04-24 2003-11-06 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen auf der Grundlage von W/O-Emulsionen mit einem Gehalt an Traubenkernöl und einem oder mehreren Siliconemulgatoren
US20040018237A1 (en) * 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
US20030232091A1 (en) * 2002-06-17 2003-12-18 Adi Shefer Stabilized retinol for cosmetic dermatological, and pharmaceutical compositions, and use thereof
DE10233740A1 (de) * 2002-07-24 2004-02-05 Basf Ag Retinoid-haltige Zubereitungen
FR2843125B1 (fr) * 2002-08-02 2012-11-16 Coletica Principes actifs stimulant les beta-defensives humaines de type 2 et/ou de type 3, et compositions cosmetiques ou pharmaceutiques comprenant de tels principes actifs
KR101534381B1 (ko) * 2002-08-12 2015-07-09 론자 인코포레이티드 항균 조성물
US20050042233A1 (en) * 2003-08-21 2005-02-24 Christopher Marrs Stabilized compositions containing an oxygen-labile active agent and a fungal extract
US20050042306A1 (en) * 2003-08-21 2005-02-24 Christopher Marrs Stabilized compositions containing an oxygen-labile active agent
US20050058673A1 (en) * 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
US20050112078A1 (en) * 2003-11-13 2005-05-26 Sekhar Boddupalli Plant-derived protein extract compositions and methods
AU2005222995B2 (en) * 2004-03-15 2010-08-26 3M Innovative Properties Company Immune response modifier formulations and methods
AU2006223137A1 (en) 2005-03-10 2006-09-21 3M Innovative Properties Company Methods of reducing microbial contamination
BRPI0608691A2 (pt) 2005-03-10 2010-12-07 3M Innovative Properties Co composição antimicrobiana, e, métodos para matar ou inativar microorganismos em tecido da mucosa de um mamìfero, para tratar uma lesão ou ferimento infectado, para descolonização de microorganismos, para proporcionar eficácia antimicrobiana residual sobre uma superfìcie e para tratar uma condição
WO2006099325A2 (en) 2005-03-10 2006-09-21 3M Innovative Properties Company Methods of treating ear infections
FR2894827B1 (fr) * 2005-12-21 2010-10-29 Galderma Res & Dev Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation,et leurs utilisations
JP4222370B2 (ja) * 2006-01-11 2009-02-12 セイコーエプソン株式会社 デバッグ支援装置及びデバッグ処理方法をコンピュータに実行させるためのプログラム
EP2155186A2 (de) * 2007-05-11 2010-02-24 Galderma Research & Development Pharmazeutische oder kosmetische präparate zur topischen und/oder parenteralen anwendung, verfahren zu ihrer herstellung und ihre anwendung
CA2686558A1 (fr) * 2007-05-11 2008-12-11 Galderma Research & Development Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
CA2686556A1 (fr) * 2007-05-11 2008-12-11 Galderma Research & Development Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
CA2686505A1 (fr) * 2007-05-11 2008-11-20 Galderma Research & Development Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
JP2010529233A (ja) * 2007-05-30 2010-08-26 ダウ・コーニング・コーポレイション 天然オイルから誘導されるシリコーンコポリマーおよびシリコーンエラストマー
US9387160B2 (en) 2008-12-22 2016-07-12 Johnson & Johnson Consumer Holdings France Composition and method of treating skin conditions
WO2011065251A1 (ja) 2009-11-24 2011-06-03 株式会社 資生堂 紫外線吸収剤包接粘土鉱物及びこれを含有する化粧料
US8410079B2 (en) 2010-08-06 2013-04-02 Island Kinetics Chirally correct retinal cyclodextrin hemiacetals for clarifying skin complexion
EP2685962A1 (de) 2011-03-17 2014-01-22 Transdermal Biotechnology, Inc. Topische stickoxidsysteme sowie verfahren zu ihrer verwendung
KR20130138551A (ko) * 2012-06-11 2013-12-19 한국콜마주식회사 점도 안정화 특성을 갖는 조성물
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US10226550B2 (en) * 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
WO2019130359A1 (en) * 2017-12-29 2019-07-04 Matex Lab S.P.A. Method to prepare a filler with a hyaluronic acid base comprising a neutralization step
ES2965417T3 (es) * 2017-12-29 2024-04-15 Matex Lab S P A Método para preparar relleno con una base de ácido hialurónico, que comprende una etapa de neutralización
CN112294693B (zh) * 2019-07-26 2021-07-20 珀莱雅化妆品股份有限公司 一种视黄醇及其衍生物的超分子制剂及其制备方法

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US33845A (en) * 1861-12-03 Improvement in harvesting-machines
GB1126289A (en) * 1966-05-12 1968-09-05 Hoffmann La Roche Water-dispersible water-free vitamin preparations and a process for the manufacture thereof
US3622668A (en) * 1969-08-27 1971-11-23 Joe B Moss Method of promoting scar-free healing of skin lacerations
US3729568A (en) * 1969-09-23 1973-04-24 Johnson & Johnson Acne treatment
ZA713539B (en) * 1970-06-23 1972-02-23 Hoffmann La Roche Pharmaceutical compositions
US3906108A (en) * 1973-10-12 1975-09-16 Johnson & Johnson Stabilized tretinoin cream emulsion
US4011323A (en) * 1974-03-18 1977-03-08 Sandoz, Inc. Bi-4-[1-(quinazolinyl-4)piperidyls] and bis{4-[1-(quinazolinyl-4)piperidyl]alkanes}
US4011313A (en) * 1974-06-07 1977-03-08 Syntex (U.S.A.) Inc. Medicament preparations
US4154823A (en) * 1976-06-10 1979-05-15 Schutt Steven R Skin treatment compositions and methods of using same
US4333924A (en) * 1978-08-09 1982-06-08 Beecham Group Limited Retinol acetate skin-care compositions
US4248861A (en) * 1979-02-21 1981-02-03 Schutt Steven R Skin treatment methods
US4247547A (en) * 1979-03-19 1981-01-27 Johnson & Johnson Tretinoin in a gel vehicle for acne treatment
US4371673A (en) * 1980-07-21 1983-02-01 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble forms of retinoids
JPH0244806B2 (ja) * 1981-09-07 1990-10-05 Sunstar Kk Bitaminaoanteinihaigoshitanyukakeihifugaiyozaisoseibutsu
US4454159A (en) * 1981-12-28 1984-06-12 Albert Musher Dermatological treatment preparations
DE3372843D1 (en) * 1982-05-15 1987-09-10 Beecham Group Plc Skin treatment compositions
US4505902A (en) * 1982-09-15 1985-03-19 Millard Mary A Skin treatment preparation
US4604281A (en) * 1983-03-21 1986-08-05 Charles Of The Ritz Group Ltd. Cosmetic and skin treatment compositions containing acetylated sterols
GB2141626B (en) * 1983-04-25 1987-01-28 Kao Corp Cinnamic acid derivatives for lightening melanin pigmentation of skin
US4481186A (en) * 1983-05-27 1984-11-06 Charles Of The Ritz Group Ltd. Non-irritating cosmetic composition containing glucamine fatty acid emulsifier soap
JPH0832621B2 (ja) * 1985-02-28 1996-03-29 株式会社資生堂 皮膚外用剤
JPS60181014A (ja) * 1984-02-27 1985-09-14 Ichiro Shibauchi 浴剤およびその製造方法
EP0158090B1 (de) * 1984-03-07 1990-08-29 Roshdy Dr. Ismail Mittel zur Behandlung und zum Schutz der Haut
US4695452A (en) * 1984-10-10 1987-09-22 Gannis Peter M Cosmetic stick
SU1329743A1 (ru) * 1984-12-19 1987-08-15 Украинский Научно-Исследовательский Институт Мясной И Молочной Промышленности Композици дл производства молочного продукта дл детского и диетического питани
US5348943A (en) * 1985-02-08 1994-09-20 Procyte Corporation Cosmetic and skin treatment compositions
WO1986006275A1 (en) * 1985-04-22 1986-11-06 Avon Products, Inc. Composition and method for reducing wrinkles
JPS62419A (ja) * 1985-06-26 1987-01-06 Shiseido Co Ltd 脂溶性ビタミン含有水溶性剤
FR2584925B1 (fr) * 1985-07-17 1987-11-27 Bosserelle Micheline Composition de corps gras d'origine vegetale pour usage cosmetique
US4603046A (en) * 1985-08-23 1986-07-29 Charles Of The Ritz Group Ltd. Improved sunscreen or sunblock composition
US4742066A (en) * 1986-03-17 1988-05-03 Charles Of The Ritz Group Ltd. Skin treatment composition and method
US4847267A (en) * 1986-03-17 1989-07-11 Charles Of The Ritz Group Ltd. Skin treatment composition and method
US4970216A (en) * 1986-03-17 1990-11-13 Richardson Vicks, Inc. Skin treatment composition and method
ZA872460B (en) * 1986-04-07 1987-12-30 Bristol Myers Co Stable injectable antiemetic compositions
JPH0643390B2 (ja) * 1986-04-08 1994-06-08 久光製薬株式会社 アザシクロアルカン誘導体
FR2597345B1 (fr) * 1986-04-22 1990-08-03 Oreal Composition cosmetique ou pharmaceutique a base d'une dispersion aqueuse de spherules lipidiques.
NL8601767A (nl) * 1986-07-07 1988-02-01 Schreuder Chem Adviesbureau Huidbruiningsmiddel.
JPS6383021A (ja) * 1986-09-26 1988-04-13 Kao Corp 内服液剤組成物
US4863970A (en) * 1986-11-14 1989-09-05 Theratech, Inc. Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
JPS63135309A (ja) * 1986-11-28 1988-06-07 Shiseido Co Ltd 皮膚外用剤
JPS63188609A (ja) * 1987-01-30 1988-08-04 Sansho Seiyaku Kk 着色を防止した外用剤
ATE110255T1 (de) * 1987-05-11 1994-09-15 Procyte Corp Gebrauch von ghl-cu derivaten für die herstellung eines medikaments zur stimulierung des haarwachstums.
JP2506384B2 (ja) * 1987-09-25 1996-06-12 三省製薬株式会社 外用剤
US4769234A (en) * 1987-10-06 1988-09-06 Peter M. Stephan Center Ltd. Skin care compositions containing polyvalent equine immune serum
LU87030A1 (fr) * 1987-10-28 1989-05-08 Oreal Utilisation en cosmetique de nouvelles substances a titre de reflecteurs du rayonnement infrarouge,compositions cosmetiques les contenant et leur utilisation pour la protection de l'epiderme humain contre le rayonnement infrarouge
JP2614474B2 (ja) * 1988-01-20 1997-05-28 サンスター株式会社 美白化粧料
IL88961A (en) * 1988-01-29 1992-07-15 Basf Ag Stable mixtures containing oxidation-sensitive compounds
JPH01246208A (ja) * 1988-03-28 1989-10-02 Shiseido Co Ltd 皮膚外用剤
AU616538B2 (en) * 1988-07-08 1991-10-31 Shiseido Company Ltd. Silicone type cinnamic acid derivative, preparation method thereof, uv-ray absorber, and external skin treatment agent
US4906457A (en) * 1988-09-06 1990-03-06 Washington State University Research Foundation, Inc. Compositions and methods for reducing the risk of sunlight and ultraviolet induced skin cancer
JPH02142713A (ja) * 1988-11-25 1990-05-31 Shiseido Co Ltd 皮膚外用剤
DE69029804T2 (de) * 1989-06-07 1997-09-04 Gail S Bazzano VEHIKEL MIT LANGSAMER FREISETZUNG ZUR VERMINDERUNG DER HAUTREIZUNG TOPISCHER retinoidhaltiger MITTEL
FI904753A0 (fi) * 1989-10-02 1990-09-27 Bristol Myers Squibb Co Emulgerade tretinoinkraemkompositioner med foerbaettrad stabilitet.
US5061480A (en) * 1989-11-03 1991-10-29 Marchese Co., Inc. Tanning composition
AU639063B2 (en) * 1990-01-29 1993-07-15 Johnson & Johnson Consumer Products, Inc. Skin care compositions
US5102654A (en) * 1990-04-18 1992-04-07 Revlon, Inc. Nail enamel emulsion lacquer comprising a water phase and a lacquer phase
US5246611A (en) * 1990-05-09 1993-09-21 The Procter & Gamble Company Non-destructive carriers for cyclodextrin complexes
US5082661A (en) * 1990-09-26 1992-01-21 Elizabeth Arden Co., Division Of Conopco, Inc. Odorless cosmetic compositions in gelatin capsules
FR2668930B1 (fr) * 1990-11-09 1995-02-17 Oreal Composition cosmetique, pharmaceutique ou alimentaire comportant une dispersion aqueuse de vesicules lipidiques.
JP2928892B2 (ja) * 1990-11-27 1999-08-03 三洋化成工業株式会社 外科用接着剤
DE4100490C1 (de) * 1991-01-10 1992-03-05 Goldwell Ag, 6100 Darmstadt, De
GB9109965D0 (en) * 1991-05-07 1991-07-03 Unilever Plc Cosmetic composition
KR100250700B1 (ko) * 1991-06-27 2000-07-01 차알스 제이. 메츠 안정화된 레티노이드 함유 피부 보호용 조성물
SE9102890D0 (sv) * 1991-10-07 1991-10-07 Hans Evers Insektsrepelleringsmedel
US5281196A (en) * 1992-05-22 1994-01-25 Sultenfuss Thomas J Skin treatment composition and method of use

Also Published As

Publication number Publication date
EP1433477A3 (de) 2004-10-20
EP1714640A1 (de) 2006-10-25
WO1994001074A1 (en) 1994-01-20
KR100295030B1 (ko) 2001-09-17
EP1433477B1 (de) 2007-06-27
EP0608433B1 (de) 2004-05-19
ES2221921T3 (es) 2005-01-16
EP0608433A1 (de) 1994-08-03
US6024941A (en) 2000-02-15
ES2289370T3 (es) 2008-02-01
ATE266999T1 (de) 2004-06-15
EP1433477A2 (de) 2004-06-30
US5484816A (en) 1996-01-16
EP0608433A4 (de) 1998-09-16

Similar Documents

Publication Publication Date Title
ATE365530T1 (de) Retinolthaltiges, stabilisiertes hautpflegemittel zur äusserlichen anwendung
HUP9801607A2 (hu) Retinoidokat és liposzómákat tartalmazó bőrápoló készítmény
CA2135575A1 (fr) Composition cosmetique contenant en tant qu'agent reducteur un n-mercapto-alkyl alcanediamide ou l'un de ses sels cosmetiquement acceptable
DK0578077T3 (da) Præparater, der indeholder retinsyrer og tocopherol
ATE123787T1 (de) Herstellung von peroxid enthaltenden perfluorpolyäthern.
DE69319440T2 (de) Herstellung von pharmazeutischen zusammensetzungen, die calcitonin enthalten
FR2713635B1 (fr) Nouveaux composés propynyl bi-aromatiques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
BR9300707A (pt) Composicao para o tratamento dos cabelos e processo de condicionamento dos cabelos
DE69435330D1 (de) Verwendung von Botulinumtoxin Typ B zur Herstellung eines Medikaments zur Behandlung von Muskelkrämpfen
ATE124253T1 (de) Verwendung von pharmazeutischen und kosmetischen präparaten mit mischmicellen.
EP0057837A3 (en) Hair treatments
ATE15442T1 (de) Haarbehandlungsmittel des typs vorshampoo.
DE69326776D1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
KR930012022A (ko) 뇌조직 보호용 모다피닐(Modafinil)
NZ314839A (en) 1,25-Dihydroxy-16,23Z-diene-20-epi-16-ene-cholecalciferol (Vitamin D3) analogues
EP0681831A3 (de) Verwendung von Extracten aus filamentösen Bakterien als kosmetische Mittel gegen Hautaltern.
DE69629989D1 (de) Präparate zur äusserlichen anwendung zur behandlung von dermatosen
MY130044A (en) Retinoid composition
IT1282778B1 (it) Vitamina "e" acetato quale prodotto per applicazione topica
ATE227557T1 (de) Verwendung von zahnpflegemitteln enthaltend bovines kolostrum
ES2091981T3 (es) Procedimiento para la fabricacion de preparaciones de crema estables, hidrofilas o ambifilas, que contienen componentes vesiculares, asi como el uso de las mismas.
ATE151774T1 (de) Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
DK671087D0 (da) Anvendelse af 5-aryl-3h-1,2,4-triazol-3-oner som antikonvulsiva
DK0579939T3 (da) Phospholipidderivater
DE69307197T2 (de) Verwendung von 24,25-Dihydroxyvitamin-D3 zur Herstellung eines Arzneimittel zur Behandlung der Rachitis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties